Introduction
Various self-report instruments have been developed to assess symptoms related to eating disorders. The widely used Eating Attitudes Test (EAT-40: [11] ; EAT-26: [12] ) and the Eating Disorder Inventory (EDI: [13] ; EDI-2: [10] ; EDI-3: [9] ) for example, were designed to explore cognitive and behavioural symptoms of eating disorders (ED). These instruments provide information helpful in understanding the patient. As the psychopathology related to ED is very heterogeneous, such descriptive information is particularly relevant in individual cases.
Anorexia Nervosa (AN) can develop from about 8 years of age, reaching a peak between 15 and 18 years. Bulimia Nervosa (BN) becomes more common in young adulthood [14] . Within these age-groups, gathering data from the patients' parents and including them in the treatment is very important, because patients suffering from ED often deny or minimize their own disorder [4, 15, 16, 18, 20] .
The Anorectic Behavior Observation Scale (ABOS) developed by Vandereycken and Meermann [19] assesses symptoms of patients suffering from AN and BN based on her or his parents' or carers' observations. The ABOS can be a useful instrument for the evaluation of the course of eating disorders, e.g. before and after treatment. Moreover, it can be applied for screening subjects in whom the eating disorder appears to be in an early stage. So far the ABOS has been used mainly in adolescents from the age of 12 years on. Vandereycken [18] confirmed the validity and reliability of the Dutch version of the ABOS, and Uehara et al. [17] approved its three-factor structure in a Japanese sample.
The aim of this study was (1) to confirm the threefactor structure of the ABOS using data from a German sample; and (2) to assess the validity and clinical usefulness of the German version of the ABOS in a clinical eating disorder sample.
Method j Subjects
Informed consent was obtained from the participants and their parents. The study was approved by the Institutional Review Board. We analysed the ABOSdata (German version) from 101 female ED in-and outpatients recruited from the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Charité-Universitätsmedizin Berlin (Germany). Sixty-three patients suffered from AN restricting subtype (ANR), 17 from AN binge-purge subtype (ANBP), and 21 from BN. All ED patients met the DSM-IV criteria for ED [2] and were aged between 12 and 18 years. AN was diagnosed by a structured interview (SIAB; [6] [7] [8] ) that assesses the prevalence and severity of specific eating-related pathology over the past 3 months according to DSM-IV diagnostic criteria for people aged between 12 and 65 years. Inter-rater reliability of the SIAB is high, Cronbach's alpha coefficients range between 0.43 and 0.91 [8] . Clinically experienced and trained research assistants under the supervision of the attending child and adolescent psychiatrist conducted the interviews. Two patients had to be excluded due to missing ABOS data. Patients suffering from ED other than AN and BN were not included in the study. All parents knew about the diagnoses of their child. Socioeconomic status (SES) was measured on an eleven-point scale assessing the parents' self-reported occupational status [5] . The scale places each occupation into one of eleven categories (1 = unskilled laborer, 6 = professional employed, 7 = unskilled self-employed, 11 = professional selfemployed). We distinguished three SES groups: High (groups 5, 6, 10, 11; e.g., manager, physician), middle (groups 3, 4, 9; e.g., electrician, nurse) and low (groups 1, 2, 7, 8; e.g., cashier, textile machine operator).
Furthermore, the questionnaire was administered to 134 female controls matched for age and SES drawn from German high schools. Total body height (in cm) and body mass (in kg) were measured using standard techniques, and Body Mass Index (BMI) was calculated. Control subjects with BMI < 18 and >24 or Tscores above 59 on the two broadband scales and the total problem scale of the child behavior checklist (CBCL) were excluded from the study [1] . Sixteen participants had to be excluded due to missing CBCL or ABOS values, and also due to T-scores above 59 on the subscales or on the total problem scale of the CBCL. Table 1 shows the sociodemographic characteristics of all subjects.
j Measurement
ABOS
The ABOS, originally developed by Vandereycken and Meermann [19] , evaluates a patient's eating behaviour based on information obtained by his or her relatives. It consists of 30 dichotomous items to be answered with Ôyes' (2 points) or Ôno' (0 points) if relatives are certain, and Ô?' (1 point) if relatives are doubtful about the answer. The higher the total score, the more pathological the subject is regarded (highest score possible = 60). Relatives should base their ratings of the 30 items on observations of the patient during the past month at home. The reliability and validity of the ABOS have been confirmed by Vandereycken [18] . The original version showed For the German version, ABOS-items were first translated into German by an independent translator. To assure adequate item-wordings in the German version, the German text was then translated back to English by a second independent translator. The two English versions (original and back-translation) were regarded as similar enough to accept the German translation by an English native speaker. Table 2 presents item examples of the ABOS.
j Statistical analysis
Two analyses were conducted to evaluate the theoretical structure (i.e., three factors) of the scale: First, internal consistency was assessed using Cronbach's alpha. Second, confirmatory factor analysis was conducted to test whether our data fitted the original three-factor model proposed by Vandereycken [18] using the analysis of moment structure (AMOS) version 4 statistical software package. Chi-square values to degrees of freedom ratios (CMIN/df), root mean square residual (RMR), goodness of fit index (GFI), adjusted GFI (AGFI), were calculated as the respective standardised goodness of fit indices in the confirmatory model. The following criteria were used to indicate an appropriate fit of the model with the present data: CMIN/df < 2.0; GFI > 0.9; AGFI > 0.9; RMR < 0.08. Also, the receiver operating characteristics (ROC) curve of the ABOS was calculated to assess the discriminant capacity of the questionnaire; sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were specified. Table 1 shows sociodemographic characteristics, body mass indexes (BMI (kg/m 2 )) and ABOS total score in the four groups. There were no significant differences regarding age and SES. As expected, there was a statistically significant difference in mean BMI (kg/m 2 ). Scheffé post-hoc comparisons showed a significant lower BMI (kg/m 2 ) in ANR patients than ANBP patients (P < 0.05), BN patients (P < 0.001), and healthy controls (P < 0.001). Furthermore, ANBP patients had a significant lower BMI (kg/m 2 ) than BN patients (P < 0.001) and normal controls (P < 0.001). No significant differences in BMI (kg/m 2 ) were found between BN patients and healthy controls (P = 0.99).
Results j Descriptives and group comparisons
j Reliability (internal consistency)
Cronbach's alpha was used to evaluate the reliability of the German version of the ABOS. Internal consistencies of the three factors and the total score were high for the entire sample, but much lower for the two subsamples (see Table 3 ).
j Confirmatory factor analysis (CFA)
Comparisons of the goodness-of-fit indices between the original Belgian model, the Japanese and the German model are shown in Table 4 . The original three-factor model [18] fits our data relatively well as indicated by CMIN/df, GFI, AGFI, and RMR. Inter- ested readers can contact the authors for original CFA data. The global indices of goodness of fit derived from the original study [18] showed an equally low or slightly lower fit on GFI, AGFI, and CMIN/df. RMR was the only parameter that indicated a better fit in the original Belgian data than in the present study. In the Japanese study [17] slightly better or equal fit on GFI, AGFI, CMIN/df and RMR were found.
j Sensitivity, specificity, PPV and NPV
In our sample a score of ‡23 as cut-off yielded the best sensitivity and specificity possible. Table 5 summarizes sensitivity, specificity, PPV and NPV of the ABOS questionnaire for the detection of ED. The ROC curve is presented in Fig. 1 .
Discussion
According to our findings, the ABOS can be used as a valid and reliable screening tool for ED in adolescents (in addition to existing self-report instruments). Confirmatory factor analysis using data from a German sample gives support for the three-factor structure proposed in the original Belgian study [18] . It was found that the internal consistency of the 30-item instrument was high for the total sample. However, reliability for the two subsamples was much lower; a fact that can largely be explained by the massively decreased intragroup variance in the subsamples compared to the total sample [3] . Reliability of the German ABOS clearly needs closer scrutiny in a population-based sample (see below). Using a total cut-off score of ‡23, the ABOS offered excellent levels of sensitivity and specificity. A limitation of this study is that based on the current sample (a clinical ED subsample and a non-clinical school-based sample), it is not possible to derive a cut-off score that would be appropriate for early identification of ED in the population that likely come with lower ABOS scores. Rather, the cut-off score ‡23 informs about the test value that best discriminates girls that already have an ED in need for treatment from a school-based sample of girls. Future studies should examine, whether these levels of sensitivity, specificity, and predictive values can be replicated when screening for ED cases within the population.
In conclusion, the German version of the ABOS could be particularly useful in the early stages of an ED, when patients show a tendency to deny or minimize their problems [20] . The parents' viewpoint seems to be a valuable source of information for both the assessment and treatment of ED in children and adolescents. 
